These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18978292)

  • 1. Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma.
    Targhetta C; Cabras MG; Angelucci E
    Haematologica; 2008 Nov; 93(11):e66. PubMed ID: 18978292
    [No Abstract]   [Full Text] [Related]  

  • 2. Health care-associated transmission of hepatitis B and C viruses in hemodialysis units.
    Fabrizi F; Martin P
    Clin Liver Dis; 2010 Feb; 14(1):49-60; viii. PubMed ID: 20123439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Status of hepatitis C in Guangzhou from 2005 to 2008].
    Lin CS; Zhao ZX; Zhang XH; Guo XY; Li TG; Chong YT; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):63-4. PubMed ID: 20128974
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B and hepatitis C in 2009.
    Marcellin P
    Liver Int; 2009 Jan; 29 Suppl 1():1-8. PubMed ID: 19207959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.
    Koo YX; Tan DS; Tan BH; Quek R; Tao M; Lim ST
    J Clin Oncol; 2009 May; 27(15):2570-1; author reply 2571-2. PubMed ID: 19364951
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
    J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)].
    Thimme R; Heim M; Baumert TF; Nassal M; Moradpour D
    Dtsch Med Wochenschr; 2014 Mar; 139(13):655-9. PubMed ID: 24648178
    [No Abstract]   [Full Text] [Related]  

  • 8. Eliminating hepatitis from the Eastern Mediterranean Region.
    Fikri M
    East Mediterr Health J; 2017 Aug; 23(7):459-460. PubMed ID: 28853128
    [No Abstract]   [Full Text] [Related]  

  • 9. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
    Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rx for B and C.
    Gibbs WW
    Sci Am; 1999 Mar; 280(3):17-20. PubMed ID: 10048231
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-analyses on viral hepatitis.
    Gluud LL; Gluud C
    Infect Dis Clin North Am; 2009 Jun; 23(2):315-30. PubMed ID: 19393912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlights in the discovery of antiviral drugs: a personal retrospective.
    De Clercq E
    J Med Chem; 2010 Feb; 53(4):1438-50. PubMed ID: 19860424
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hepatitis B and C virus infection].
    Trautwein C; Tacke F
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S87-9. PubMed ID: 12817332
    [No Abstract]   [Full Text] [Related]  

  • 14. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C in 2013: HCV causes systemic disorders that can be cured.
    Negro F
    Nat Rev Gastroenterol Hepatol; 2014 Feb; 11(2):77-8. PubMed ID: 24275792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation in viral hepatitis: prevention of recurrence.
    Roche B; Samuel D
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1153-69. PubMed ID: 19187873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral hepatitis: towards the eradication of HCV and a cure for HBV.
    Marcellin P
    Liver Int; 2016 Jan; 36 Suppl 1():5-6. PubMed ID: 26725890
    [No Abstract]   [Full Text] [Related]  

  • 18. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
    Wang FS; Zhang Z
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
    Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
    Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy and immunosuppression in patients with hepatitis B or C].
    Sitruk V; Fain O; Gordien E; Ganne-Carrié N; Deny P; Beaugrand M; Trinchet JC
    Gastroenterol Clin Biol; 2001 Nov; 25(11):1002-7. PubMed ID: 11845054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.